Um den gesellschaftlichen Nutzen pharmazeutischer Innovationen abzuschätzen, bedarf es adäquater Beurteilungskriterien. Nach einem empirischen Abriß über die Entwicklung der Arzneimittelausgaben erörtern die Autoren die beurteilungsrelevanten gesamtwirtschaftlichen Ziele. Auf...

In this paper we predict the pure demographic effect on medical expenditure of the German Statutory Health Insurance Scheme. To isolate this effect, we assume that the age-specific expenditure for medical treatment as observed in 1991 remains constant over the whole prediction period (1991 until...

This paper analyses the pure demographic effect on medical expenditure and the contribution rate of the German Statutory Health Insurance Scheme. To isolate this effect, we assume that the age-specific expenditure for medical treatment as estimated in 1995 remains constant over the whole...

In this paper we predict the pure demographic effect on medical expenditure of the German Statutory Health Insurance Scheme. To isolate this effect, we assume that the age-specific expenditure for medical treatment as observed in 1991 remains constant over the whole prediction period (1991 until...

This paper analyses the pure demographic effect on medical expenditure and the contribution rate of the German Statutory Health Insurance Scheme. To isolate this effect, we assume that the age-specific expenditure for medical treatment as estimated in 1995 remains constant over the whole...